Study sites in Phoenix, Arizona, Houston, Texas, and Chicago, Illinois have started screening for the study. Remaining study sites in the following cities will begin screening later this year and into early 2020 https://www.rettsyndrome.org/acadia-announces-launch-of-phase-3-lavender-study-for-trofinetide
12-18 months time get results could be a reality. Hopefully not
NEU Price at posting:
$2.29 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)